Australia's largest stock trading and investment forum Australia's #1 stock forum

PER

Click for more information

6.41%

7.3¢ percheron therapeutics limited

6 months passed since first patient, page-3

First 3 Last

Share
Profile

Follow
dalts66

4,267 Posts.

1990

11/01/24

16:26

Post #: 71835616
Share

Originally posted by Mr Perry: ↑

Hi all

The first patient was dosed on 6 June 2023, and therefore 6 months has now passed. (ANP announcement dates 8 Jun 23)

What happens now to this first patient.? Does all treatment stop until all results are assessed in H2/2024? Or will this boy continue with his current dose? Does anyone know?

Given the delays in recruitment, is there going to be a delay in treatment for the early pioneering boys?

Appreciate anyone’s thoughts / understanding on what typically occurs in such trials where results are staggered

good luck to all. Mr P

Expand

Have a read of the 8th June 2022 announcement of the first boy receiving treatment. It explains what happens.
Effectively after 24 weeks they transition into an open lable expansion trial receiving either a 25 or 50 dose of atl1102. Any placebo dosing would finish and be replaced.

PER Price at posting: 5.8¢ Sentiment: Buy Disclosure: Held
17 Upvote

0 Great analysis

Reply

There are more pages in this discussion • 159 more messages in this thread...

First 3 Last

Add PER (ASX) to my watchlist

(20min delay)
Last 7.3¢		Change -0.005(6.41%)		Mkt cap ! $65.81M

Open	High	Low	Value	Volume
7.8¢	7.8¢	7.3¢	$35.42K	473.2K

Buyers (Bids)

No.	Vol.	Price($)
2	221465	7.3¢

Sellers (Offers)

Price($)	Vol.	No.
7.5¢	9000	1

View Market Depth

No.	Vol.	Price($)
2	221465	0.073
3	322000	0.072
1	20000	0.071
4	399887	0.070
2	203981	0.069

Price($)	Vol.	No.
0.075	9000	1
0.077	121601	1
0.079	120000	1
0.080	102781	2
0.081	26315	1

Last trade - 16.10pm 15/05/2024 (20 minute delay)

PER (ASX) Chart

SPONSORED BY